Literature DB >> 31424918

N-Terminal Acetylation Affects α-Synuclein Fibril Polymorphism.

Matthew D Watson1, Jennifer C Lee1.   

Abstract

Parkinson's disease etiology involves amyloid formation by α-synuclein (αSyn). In vivo, αSyn is constitutively acetylated at the α-amino N-terminus. Here, we find N-terminally acetylated αSyn (Ac-αSyn) aggregates more slowly than non-acetylated αSyn (NH3-αSyn) with significantly reduced sensitivity to thioflavin T (ThT). Fibril differences were characterized by transmission electron microscopy, circular dichroism spectroscopy, and limited proteolysis. Interestingly, the low-ThT Ac-αSyn fibrils seed both acetylated and non-acetylated αSyn and faithfully propagate the low-ThT character through several generations, indicating a stable fibril polymorph. In contrast, the high-ThT NH3-αSyn seeds lose fidelity over subsequent generations. Despite it being outside of the amyloid core, the chemical nature of the N-terminus modulates αSyn aggregation and fibril polymorphism.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31424918      PMCID: PMC6721997          DOI: 10.1021/acs.biochem.9b00629

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  29 in total

1.  N-terminal acetylation of α-synuclein induces increased transient helical propensity and decreased aggregation rates in the intrinsically disordered monomer.

Authors:  Lijuan Kang; Gina M Moriarty; Lucy A Woods; Alison E Ashcroft; Sheena E Radford; Jean Baum
Journal:  Protein Sci       Date:  2012-06-11       Impact factor: 6.725

Review 2.  Molecular mechanism of Thioflavin-T binding to amyloid fibrils.

Authors:  Matthew Biancalana; Shohei Koide
Journal:  Biochim Biophys Acta       Date:  2010-04-22

3.  Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations.

Authors:  Wenxue Li; Neva West; Emanuela Colla; Olga Pletnikova; Juan C Troncoso; Laura Marsh; Ted M Dawson; Pekka Jäkälä; Tobias Hartmann; Donald L Price; Michael K Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

4.  Characterization of semisynthetic and naturally Nα-acetylated α-synuclein in vitro and in intact cells: implications for aggregation and cellular properties of α-synuclein.

Authors:  Bruno Fauvet; Mohamed-Bilal Fares; Filsy Samuel; Igor Dikiy; Anurag Tandon; David Eliezer; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

5.  Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions.

Authors:  Masato Hasegawa; Hideo Fujiwara; Takashi Nonaka; Koichi Wakabayashi; Hitoshi Takahashi; Virginia M-Y Lee; John Q Trojanowski; David Mann; Takeshi Iwatsubo
Journal:  J Biol Chem       Date:  2002-10-10       Impact factor: 5.157

6.  Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.

Authors:  John P Anderson; Donald E Walker; Jason M Goldstein; Rian de Laat; Kelly Banducci; Russell J Caccavello; Robin Barbour; Jiping Huang; Kristin Kling; Michael Lee; Linnea Diep; Pamela S Keim; Xiaofeng Shen; Tim Chataway; Michael G Schlossmacher; Peter Seubert; Dale Schenk; Sukanto Sinha; Wei Ping Gai; Tamie J Chilcote
Journal:  J Biol Chem       Date:  2006-07-17       Impact factor: 5.157

7.  Conformational properties of alpha-synuclein in its free and lipid-associated states.

Authors:  D Eliezer; E Kutluay; R Bussell; G Browne
Journal:  J Mol Biol       Date:  2001-04-06       Impact factor: 5.469

Review 8.  α-Synuclein posttranslational modification and alternative splicing as a trigger for neurodegeneration.

Authors:  Katrin Beyer; Aurelio Ariza
Journal:  Mol Neurobiol       Date:  2012-08-25       Impact factor: 5.590

9.  Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro.

Authors:  Jacqueline Burré; Manu Sharma; Theodoros Tsetsenis; Vladimir Buchman; Mark R Etherton; Thomas C Südhof
Journal:  Science       Date:  2010-08-26       Impact factor: 47.728

10.  Impact of N-terminal acetylation of α-synuclein on its random coil and lipid binding properties.

Authors:  Alexander S Maltsev; Jinfa Ying; Ad Bax
Journal:  Biochemistry       Date:  2012-06-14       Impact factor: 3.162

View more
  14 in total

1.  The α-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure.

Authors:  David R Boyer; Binsen Li; Chuanqi Sun; Weijia Fan; Kang Zhou; Michael P Hughes; Michael R Sawaya; Lin Jiang; David S Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-03       Impact factor: 11.205

2.  NMR unveils an N-terminal interaction interface on acetylated-α-synuclein monomers for recruitment to fibrils.

Authors:  Xue Yang; Baifan Wang; Cody L Hoop; Jonathan K Williams; Jean Baum
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-04       Impact factor: 11.205

3.  The Lys 280 → Gln mutation mimicking disease-linked acetylation of Lys 280 in tau extends the structural core of fibrils and modulates their catalytic properties.

Authors:  Harish Kumar; Jayant B Udgaonkar
Journal:  Protein Sci       Date:  2021-02-09       Impact factor: 6.725

Review 4.  Coupling chemical biology and vibrational spectroscopy for studies of amyloids in vitro and in cells.

Authors:  Matthew D Watson; Jennifer C Lee
Journal:  Curr Opin Chem Biol       Date:  2021-06-26       Impact factor: 8.972

Review 5.  Targeting α-synuclein for PD Therapeutics: A Pursuit on All Fronts.

Authors:  Margaux Teil; Marie-Laure Arotcarena; Emilie Faggiani; Florent Laferriere; Erwan Bezard; Benjamin Dehay
Journal:  Biomolecules       Date:  2020-03-03

6.  Parkinson's disease associated mutation E46K of α-synuclein triggers the formation of a distinct fibril structure.

Authors:  Kun Zhao; Yaowang Li; Zhenying Liu; Houfang Long; Chunyu Zhao; Feng Luo; Yunpeng Sun; Youqi Tao; Xiao-Dong Su; Dan Li; Xueming Li; Cong Liu
Journal:  Nat Commun       Date:  2020-05-26       Impact factor: 14.919

7.  Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises.

Authors:  Luke McAlary; Yee Lian Chew; Jeremy Stephen Lum; Nicholas John Geraghty; Justin John Yerbury; Neil R Cashman
Journal:  Front Cell Neurosci       Date:  2020-11-04       Impact factor: 5.505

8.  Molecular basis for N-terminal alpha-synuclein acetylation by human NatB.

Authors:  Sunbin Deng; Buyan Pan; Leah Gottlieb; E James Petersson; Ronen Marmorstein
Journal:  Elife       Date:  2020-09-04       Impact factor: 8.140

9.  Human NAA30 can rescue yeast mak3∆ mutant growth phenotypes.

Authors:  Adrian Drazic; Sylvia Varland
Journal:  Biosci Rep       Date:  2021-03-26       Impact factor: 3.840

Review 10.  Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson's Disease.

Authors:  Carla Ferreira; Catarina Almeida; Sandra Tenreiro; Alexandre Quintas
Journal:  Life (Basel)       Date:  2020-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.